Official registry condition

Acute Kidney Injury peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Acute Kidney Injury. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

3 profiles.

Registry update years

2016–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 85 selected PubMed records and 53 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Acute Kidney Injury unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT06337838

PeptideScanner retained ClinicalTrials.gov record NCT06337838 at 2026-11-16T01:33:21.554Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was desmopressin.

PeptideScanner change date
November 16, 2026
Cited source date
May 22, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02059460

PeptideScanner retained ClinicalTrials.gov record NCT02059460 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 15, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04416282

PeptideScanner retained ClinicalTrials.gov record NCT04416282 at 2026-11-15T21:47:40.408Z. Its registry update date was 2023-04-06, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 6, 2023
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →